CN1126432A - 用于治疗牙斑和牙龈炎的含有非阳离子型杀菌剂和碳酸氢盐的口用组合物 - Google Patents
用于治疗牙斑和牙龈炎的含有非阳离子型杀菌剂和碳酸氢盐的口用组合物 Download PDFInfo
- Publication number
- CN1126432A CN1126432A CN94192315.0A CN94192315A CN1126432A CN 1126432 A CN1126432 A CN 1126432A CN 94192315 A CN94192315 A CN 94192315A CN 1126432 A CN1126432 A CN 1126432A
- Authority
- CN
- China
- Prior art keywords
- compositions
- compositions according
- antibacterial
- toothpaste
- oral cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 208000007565 gingivitis Diseases 0.000 title abstract description 7
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 230000000844 anti-bacterial effect Effects 0.000 claims description 24
- 239000000606 toothpaste Substances 0.000 claims description 19
- 229940034610 toothpaste Drugs 0.000 claims description 19
- 210000000214 mouth Anatomy 0.000 claims description 15
- 239000000796 flavoring agent Substances 0.000 claims description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 235000013355 food flavoring agent Nutrition 0.000 claims description 11
- 229960003500 triclosan Drugs 0.000 claims description 11
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- 125000002091 cationic group Chemical group 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 8
- 239000003082 abrasive agent Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 230000002272 anti-calculus Effects 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 208000025157 Oral disease Diseases 0.000 claims description 4
- 235000011180 diphosphates Nutrition 0.000 claims description 4
- 208000030194 mouth disease Diseases 0.000 claims description 4
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 claims description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 229910001414 potassium ion Inorganic materials 0.000 claims description 3
- 239000001177 diphosphate Substances 0.000 claims description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 2
- 239000004530 micro-emulsion Substances 0.000 claims description 2
- IWONLOSVRYAOAN-UHFFFAOYSA-N 2,2-diethylhexylphosphonic acid Chemical compound C(C)C(CP(O)(O)=O)(CCCC)CC IWONLOSVRYAOAN-UHFFFAOYSA-N 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- -1 halogenated hydroxyl diphenyl ether Chemical compound 0.000 description 19
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 13
- 239000000377 silicon dioxide Substances 0.000 description 12
- 229960000581 salicylamide Drugs 0.000 description 11
- 239000000463 material Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 229940090668 parachlorophenol Drugs 0.000 description 8
- 230000003239 periodontal effect Effects 0.000 description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- 235000010356 sorbitol Nutrition 0.000 description 7
- GWEHVDNNLFDJLR-UHFFFAOYSA-N 1,3-diphenylurea Chemical compound C=1C=CC=CC=1NC(=O)NC1=CC=CC=C1 GWEHVDNNLFDJLR-UHFFFAOYSA-N 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 description 6
- 150000007942 carboxylates Chemical class 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000011775 sodium fluoride Substances 0.000 description 6
- 235000013024 sodium fluoride Nutrition 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 5
- 239000000080 wetting agent Substances 0.000 description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- 229910052783 alkali metal Inorganic materials 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 4
- 229940105329 carboxymethylcellulose Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000001475 halogen functional group Chemical group 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- 235000010215 titanium dioxide Nutrition 0.000 description 4
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 3
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
- VADKRMSMGWJZCF-UHFFFAOYSA-N 2-bromophenol Chemical group OC1=CC=CC=C1Br VADKRMSMGWJZCF-UHFFFAOYSA-N 0.000 description 3
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 3
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 208000006558 Dental Calculus Diseases 0.000 description 3
- 208000002064 Dental Plaque Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 229940091249 fluoride supplement Drugs 0.000 description 3
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 208000028169 periodontal disease Diseases 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229940085605 saccharin sodium Drugs 0.000 description 3
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NKTOLZVEWDHZMU-UHFFFAOYSA-N 2,5-xylenol Chemical compound CC1=CC=C(C)C(O)=C1 NKTOLZVEWDHZMU-UHFFFAOYSA-N 0.000 description 2
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 2
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- YCOXTKKNXUZSKD-UHFFFAOYSA-N 3,4-xylenol Chemical compound CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 2
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 229930185605 Bisphenol Natural products 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 210000004268 dentin Anatomy 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Natural products C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 210000004195 gingiva Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 229960003511 macrogol Drugs 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- TXXHDPDFNKHHGW-UHFFFAOYSA-N muconic acid Chemical compound OC(=O)C=CC=CC(O)=O TXXHDPDFNKHHGW-UHFFFAOYSA-N 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910002028 silica xerogel Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- XVOUMQNXTGKGMA-OWOJBTEDSA-N (E)-glutaconic acid Chemical compound OC(=O)C\C=C\C(O)=O XVOUMQNXTGKGMA-OWOJBTEDSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 1
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 1
- HGEFWFBFQKWVMY-DUXPYHPUSA-N 2,4-dihydroxy-trans cinnamic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1O HGEFWFBFQKWVMY-DUXPYHPUSA-N 0.000 description 1
- KUFFULVDNCHOFZ-UHFFFAOYSA-N 2,4-xylenol Chemical compound CC1=CC=C(O)C(C)=C1 KUFFULVDNCHOFZ-UHFFFAOYSA-N 0.000 description 1
- VNXWANZMRATDQM-UHFFFAOYSA-N 2-(2-phenylethyl)benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CCC1=CC=CC=C1 VNXWANZMRATDQM-UHFFFAOYSA-N 0.000 description 1
- CFSOXRGHLCXRNB-UHFFFAOYSA-N 2-(3-phenylpropyl)benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CCCC1=CC=CC=C1 CFSOXRGHLCXRNB-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- NCKMMSIFQUPKCK-UHFFFAOYSA-N 2-benzyl-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1CC1=CC=CC=C1 NCKMMSIFQUPKCK-UHFFFAOYSA-N 0.000 description 1
- RKDMDAVSHRCXQZ-UHFFFAOYSA-N 2-benzylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CC1=CC=CC=C1 RKDMDAVSHRCXQZ-UHFFFAOYSA-N 0.000 description 1
- RYNDYESLUKWOEE-UHFFFAOYSA-N 2-benzylprop-2-enoic acid Chemical compound OC(=O)C(=C)CC1=CC=CC=C1 RYNDYESLUKWOEE-UHFFFAOYSA-N 0.000 description 1
- ZIYRDJLAJYTELF-UHFFFAOYSA-N 2-bromo-4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1Br ZIYRDJLAJYTELF-UHFFFAOYSA-N 0.000 description 1
- QZVWKHMJEJUBDI-UHFFFAOYSA-N 2-butan-2-yl-4-chloro-5-methylphenol 4-chloro-3,5-dimethyl-2-propan-2-ylphenol 4-chloro-2-ethyl-3,5-dimethylphenol 4-chloro-5-methyl-2-propan-2-ylphenol Chemical compound C(C)(C)C1=C(C=C(C(=C1C)Cl)C)O.C(C)(CC)C1=CC(=C(C=C1O)C)Cl.C(C)C1=C(C=C(C(=C1C)Cl)C)O.C(C)(C)C1=CC(=C(C=C1O)C)Cl QZVWKHMJEJUBDI-UHFFFAOYSA-N 0.000 description 1
- ZXPLGLMEXWSLCX-UHFFFAOYSA-N 2-chloro-3,5-dimethylphenol Chemical compound CC1=CC(C)=C(Cl)C(O)=C1 ZXPLGLMEXWSLCX-UHFFFAOYSA-N 0.000 description 1
- UNRRZPJVYQDQPL-UHFFFAOYSA-N 2-chloro-3-ethylphenol Chemical compound CCC1=CC=CC(O)=C1Cl UNRRZPJVYQDQPL-UHFFFAOYSA-N 0.000 description 1
- FQHUWSPRTMWLFA-UHFFFAOYSA-N 2-cyclohexylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1CCCCC1 FQHUWSPRTMWLFA-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- DTQQMULENZFWGF-UHFFFAOYSA-N 2-ethyl-4-hydroxybenzoic acid Chemical compound CCC1=CC(O)=CC=C1C(O)=O DTQQMULENZFWGF-UHFFFAOYSA-N 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
- DWVXFVWWARTDCQ-UHFFFAOYSA-N 2-ethylbenzene-1,3-diol Chemical compound CCC1=C(O)C=CC=C1O DWVXFVWWARTDCQ-UHFFFAOYSA-N 0.000 description 1
- NCTHQZTWNVDWGT-UHFFFAOYSA-N 2-hexylbenzene-1,3-diol Chemical compound CCCCCCC1=C(O)C=CC=C1O NCTHQZTWNVDWGT-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- ZTMADXFOCUXMJE-UHFFFAOYSA-N 2-methylbenzene-1,3-diol Chemical compound CC1=C(O)C=CC=C1O ZTMADXFOCUXMJE-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- HHSCZZZCAYSVRK-UHFFFAOYSA-N 2-octylbenzene-1,3-diol Chemical compound CCCCCCCCC1=C(O)C=CC=C1O HHSCZZZCAYSVRK-UHFFFAOYSA-N 0.000 description 1
- UPXZHXVOMCGZDS-UHFFFAOYSA-N 2-phenylbenzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1C1=CC=CC=C1 UPXZHXVOMCGZDS-UHFFFAOYSA-N 0.000 description 1
- ONPJWQSDZCGSQM-UHFFFAOYSA-N 2-phenylprop-2-enoic acid Chemical compound OC(=O)C(=C)C1=CC=CC=C1 ONPJWQSDZCGSQM-UHFFFAOYSA-N 0.000 description 1
- MPPQGYCZBNURDG-UHFFFAOYSA-N 2-propionyl-6-dimethylaminonaphthalene Chemical compound C1=C(N(C)C)C=CC2=CC(C(=O)CC)=CC=C21 MPPQGYCZBNURDG-UHFFFAOYSA-N 0.000 description 1
- CYUZOYPRAQASLN-UHFFFAOYSA-N 3-prop-2-enoyloxypropanoic acid Chemical compound OC(=O)CCOC(=O)C=C CYUZOYPRAQASLN-UHFFFAOYSA-N 0.000 description 1
- KLSLBUSXWBJMEC-UHFFFAOYSA-N 4-Propylphenol Chemical compound CCCC1=CC=C(O)C=C1 KLSLBUSXWBJMEC-UHFFFAOYSA-N 0.000 description 1
- GZFGOTFRPZRKDS-UHFFFAOYSA-N 4-bromophenol Chemical compound OC1=CC=C(Br)C=C1 GZFGOTFRPZRKDS-UHFFFAOYSA-N 0.000 description 1
- WMWPTYOGAKLXQJ-UHFFFAOYSA-N 4-chloro-2-ethylphenol;4-chloro-2-methylphenol Chemical compound CC1=CC(Cl)=CC=C1O.CCC1=CC(Cl)=CC=C1O WMWPTYOGAKLXQJ-UHFFFAOYSA-N 0.000 description 1
- ABNDJFFCGNSBBB-UHFFFAOYSA-N 4-chloro-3,5-dimethyl-2-pentan-2-ylphenol 4-chloro-2-ethyl-3-methyl-6-propan-2-ylphenol Chemical compound C(C)(CCC)C1=C(C=C(C(=C1C)Cl)C)O.C(C)(C)C1=CC(=C(C(=C1O)CC)C)Cl ABNDJFFCGNSBBB-UHFFFAOYSA-N 0.000 description 1
- JPQXQTCNMSTQQH-UHFFFAOYSA-N 4-chloro-5-methyl-2-octan-2-ylphenol Chemical compound CCCCCCC(C)C1=CC(Cl)=C(C)C=C1O JPQXQTCNMSTQQH-UHFFFAOYSA-N 0.000 description 1
- BBMFSGOFUHEVNP-UHFFFAOYSA-N 4-hydroxy-2-methylbenzoic acid Chemical compound CC1=CC(O)=CC=C1C(O)=O BBMFSGOFUHEVNP-UHFFFAOYSA-N 0.000 description 1
- MNVMYTVDDOXZLS-UHFFFAOYSA-N 4-methoxyguaiacol Natural products COC1=CC=C(O)C(OC)=C1 MNVMYTVDDOXZLS-UHFFFAOYSA-N 0.000 description 1
- ZVEWFTICTSQBDM-UHFFFAOYSA-N 4-methylphenol Chemical compound [CH2]C1=CC=C(O)C=C1 ZVEWFTICTSQBDM-UHFFFAOYSA-N 0.000 description 1
- CYYZDBDROVLTJU-UHFFFAOYSA-N 4-n-Butylphenol Chemical compound CCCCC1=CC=C(O)C=C1 CYYZDBDROVLTJU-UHFFFAOYSA-N 0.000 description 1
- KNDDEFBFJLKPFE-UHFFFAOYSA-N 4-n-Heptylphenol Chemical compound CCCCCCCC1=CC=C(O)C=C1 KNDDEFBFJLKPFE-UHFFFAOYSA-N 0.000 description 1
- SZWBRVPZWJYIHI-UHFFFAOYSA-N 4-n-Hexylphenol Chemical compound CCCCCCC1=CC=C(O)C=C1 SZWBRVPZWJYIHI-UHFFFAOYSA-N 0.000 description 1
- ZNPSUQQXTRRSBM-UHFFFAOYSA-N 4-n-Pentylphenol Chemical compound CCCCCC1=CC=C(O)C=C1 ZNPSUQQXTRRSBM-UHFFFAOYSA-N 0.000 description 1
- PJHYOCWMKYASAB-UHFFFAOYSA-N 4-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC=C(O)C=C1O PJHYOCWMKYASAB-UHFFFAOYSA-N 0.000 description 1
- KZHMXWCJVAQSRH-UHFFFAOYSA-N 5-methyl-2-pentylphenol;3-methyl-4-propan-2-ylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C.CCCCCC1=CC=C(C)C=C1O KZHMXWCJVAQSRH-UHFFFAOYSA-N 0.000 description 1
- 208000010266 Aggressive Periodontitis Diseases 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- UIERETOOQGIECD-UHFFFAOYSA-N Angelic acid Natural products CC=C(C)C(O)=O UIERETOOQGIECD-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- FHTLKRZEYLEPDD-UHFFFAOYSA-N C(C)C1=CC(=C(C=C1O)C)Cl.CC=1C=C(C=C(C1Cl)C)O.CC=1C=C(C=CC1Cl)O Chemical compound C(C)C1=CC(=C(C=C1O)C)Cl.CC=1C=C(C=C(C1Cl)C)O.CC=1C=C(C=CC1Cl)O FHTLKRZEYLEPDD-UHFFFAOYSA-N 0.000 description 1
- HQMXASFUJJBUQK-UHFFFAOYSA-N C(CCCCC)C=1C(=C(C=CC1)O)Cl.C(C)(C)(CC)C=1C(=C(C=CC1)O)Cl.C(CCCC)C=1C(=C(C=CC1)O)Cl Chemical compound C(CCCCC)C=1C(=C(C=CC1)O)Cl.C(C)(C)(CC)C=1C(=C(C=CC1)O)Cl.C(CCCC)C=1C(=C(C=CC1)O)Cl HQMXASFUJJBUQK-UHFFFAOYSA-N 0.000 description 1
- YSZKUNAOJINQKI-UHFFFAOYSA-N CC=1C(=C(C=CC1)O)Cl.ClC1=C(C=CC=C1)O.C(CCCCCCC)C1=C(C=CC(=C1)Cl)O.C(CCCCCC)C1=C(C=CC(=C1)Cl)O.C1(CCCCC1)C1=C(C=CC(=C1)Cl)O.C(CCCCC)C1=C(C=CC(=C1)Cl)O.C(C)(CCC)C1=C(C=CC(=C1)Cl)O.C(CCCC)C1=C(C=CC(=C1)Cl)O Chemical compound CC=1C(=C(C=CC1)O)Cl.ClC1=C(C=CC=C1)O.C(CCCCCCC)C1=C(C=CC(=C1)Cl)O.C(CCCCCC)C1=C(C=CC(=C1)Cl)O.C1(CCCCC1)C1=C(C=CC(=C1)Cl)O.C(CCCCC)C1=C(C=CC(=C1)Cl)O.C(C)(CCC)C1=C(C=CC(=C1)Cl)O.C(CCCC)C1=C(C=CC(=C1)Cl)O YSZKUNAOJINQKI-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241001147468 Chondrus ocellatus Species 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- TXXHDPDFNKHHGW-CCAGOZQPSA-N Muconic acid Natural products OC(=O)\C=C/C=C\C(O)=O TXXHDPDFNKHHGW-CCAGOZQPSA-N 0.000 description 1
- 101800000021 N-terminal protease Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DEJQZSPNGWCHNE-UHFFFAOYSA-N OC1=CC=CC=C1Br.CC1=CC(Cl)=CC=C1O.CC1=CC(O)=CC=C1Cl.CC1=CC(O)=CC(C)=C1Cl.OC1=CC=CC=C1C1=CC=CC=C1 Chemical group OC1=CC=CC=C1Br.CC1=CC(Cl)=CC=C1O.CC1=CC(O)=CC=C1Cl.CC1=CC(O)=CC(C)=C1Cl.OC1=CC=CC=C1C1=CC=CC=C1 DEJQZSPNGWCHNE-UHFFFAOYSA-N 0.000 description 1
- 241000412169 Peria Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 102000009609 Pyrophosphatases Human genes 0.000 description 1
- 108010009413 Pyrophosphatases Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HFIGWKOFZLNOQK-UHFFFAOYSA-K [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] Chemical compound [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] HFIGWKOFZLNOQK-UHFFFAOYSA-K 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001515 alkali metal fluoride Inorganic materials 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- UIERETOOQGIECD-ARJAWSKDSA-N angelic acid Chemical compound C\C=C(\C)C(O)=O UIERETOOQGIECD-ARJAWSKDSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- OYLGJCQECKOTOL-UHFFFAOYSA-L barium fluoride Chemical compound [F-].[F-].[Ba+2] OYLGJCQECKOTOL-UHFFFAOYSA-L 0.000 description 1
- 229910001632 barium fluoride Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 1
- 229940018557 citraconic acid Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- LDCRTTXIJACKKU-ARJAWSKDSA-N dimethyl maleate Chemical compound COC(=O)\C=C/C(=O)OC LDCRTTXIJACKKU-ARJAWSKDSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- ANUSOIHIIPAHJV-UHFFFAOYSA-N fenticlor Chemical compound OC1=CC=C(Cl)C=C1SC1=CC(Cl)=CC=C1O ANUSOIHIIPAHJV-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 208000024693 gingival disease Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- TVHALOSDPLTTSR-UHFFFAOYSA-H hexasodium;[oxido-[oxido(phosphonatooxy)phosphoryl]oxyphosphoryl] phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O TVHALOSDPLTTSR-UHFFFAOYSA-H 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- LDHQCZJRKDOVOX-IHWYPQMZSA-N isocrotonic acid Chemical compound C\C=C/C(O)=O LDHQCZJRKDOVOX-IHWYPQMZSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- BSDKWFAJZDUHKQ-UHFFFAOYSA-N methoxyethene Chemical compound COC=C.COC=C BSDKWFAJZDUHKQ-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- ASHGTJPOSUFTGB-UHFFFAOYSA-N methyl resorcinol Natural products COC1=CC=CC(O)=C1 ASHGTJPOSUFTGB-UHFFFAOYSA-N 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical compound FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 description 1
- 229940074371 monofluorophosphate Drugs 0.000 description 1
- RHFUXPCCELGMFC-UHFFFAOYSA-N n-(6-cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl)-n-phenylmethoxyacetamide Chemical compound OC1C(C)(C)OC2=CC=C(C#N)C=C2C1N(C(=O)C)OCC1=CC=CC=C1 RHFUXPCCELGMFC-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- NRZWYNLTFLDQQX-UHFFFAOYSA-N p-tert-Amylphenol Chemical compound CCC(C)(C)C1=CC=C(O)C=C1 NRZWYNLTFLDQQX-UHFFFAOYSA-N 0.000 description 1
- IWDCLRJOBJJRNH-UHFFFAOYSA-N para-hydroxytoluene Natural products CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 210000002379 periodontal ligament Anatomy 0.000 description 1
- 201000006727 periodontosis Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000010672 sassafras oil Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229920001909 styrene-acrylic polymer Polymers 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种含有一种非阳离子型非水溶性杀菌剂的口用组合物,它可用于防治牙斑和牙龈炎。
Description
技术领域
本发明涉及一种具有防治牙斑和牙龈炎功效的口用组合物,它同时还可有效防治其它口腔内厌氧菌感染。
牙斑引起的疾病,包括牙周病和牙龈炎被认为与厌氧菌感染有关。牙周疾病影响到牙周组织,即牙齿周围的包埋和支持组织(即牙周韧带,牙龈,和牙槽骨)。牙龈炎和牙周炎分别是牙龈和牙周韧带的炎性病变。龈变性和牙周变性是涉及到组织的变性病变的更严重的情况。炎症和变性并发的情况被称为牙周综合症。
牙周疾病是造成成年人牙齿缺失的一个主要原因。由牙周疾病造成的牙齿缺失在35岁以后开始成为严重问题,但是据估计,早在15岁时就有4/5的人患有牙龈炎,4/10的人患有牙周炎。
通过使用洁牙剂刷牙来保持良好的口腔卫生有助于减少患牙周疾病的机会,但并不能阻止或杜绝它的发生。这是因为牙周病的引发和发展都是由微生物造成的。所以,为了预防或治疗牙周疾病,就必须使用某些方法来抑制这些微生物而不仅是简单的机械擦洗。为此目的,已经进行了大量旨在开发可有效抑制这些微生物的治疗性牙膏,漱口液,和牙周病的治疗手段的研究。
许多参考文献中公开了非阳离子型,不溶于水的杀菌剂在口用产品中的使用。其中之一是Vinson等的美国专利4,022,889。Vin-son描述了含有锌盐和诸如卤代N-水杨酰苯胺和卤代羟基二苯醚之类的杀菌剂的组合物。
另一篇揭示了非阳离子型水不溶性杀菌剂的使用的是公开于1988年8月10日的英国专利申请GB2,200,551。除了杀菌剂,组合物中还含有一种分子间脱水而成的聚磷酸盐。该盐据称可提高杀菌剂的效力。所有现有技术参考资料都在此引用作为参考。
现已发现,将杀菌剂与一种碳酸氢盐,最好是碳酸氢钠组合可显著提高杀菌剂的生物利用率和杀菌效力。这样可以使杀菌剂更有效地沉积在口腔表面,而且可获得较好的口感。
所以,本发明的目的之一是提供含有杀菌剂的改良产品。
本发明的另一目的是提供用于防治口腔疾病的更有效的产品。
本发明还有一个目的,是提供口腔疾病的治疗方法。
这些及其它目的将充分展现于以下公开内容中。
若无其它说明,在此所用的百分比和比数都按组合物的总重计。同时,若无其它说明,此处所说的对化合物所做的测定均在25℃进行。发明概述
本发明,从某些方面说,包括了含有一种水不溶性的非阳离子型杀菌剂和一种碳酸氢盐的组合物。
本发明还包括一种使用所述组合物治疗口腔疾病的方法
“口用组合物”在此表示一种产品,它在一般使用中,并不通过吞咽以达到体内吸收特定治疗药剂的目的,而是通过在口腔内停留足够长的时间,以基本上与全部牙齿表面和/或口腔组织接触,从而增强口腔活性。
“安全和有效量”在此表示在提供所需优点的同时对口腔的硬软组织都安全的足量物质。
“含有”在此表示只要所列物质能发挥它们的所需功效,可在本发明组合物中结合使用各种附加组分。
“载体”在此表示在药学上被认可的,可使本组合物用于口腔的合适的载体。本发明的详细说明
从某方面说,本发明涉及制备一种含有一种碳酸氢盐和水不溶性的,非阳离子型的杀菌剂的组合物。以下将详细说明组合物中的必需组分和可选组分。本发明的组合物中最好基本不含钾离子(例如,约少于0.001%的钾离子)。必需组分:杀菌剂
以下给出的是用于本发明组合物中的水不溶性非阳离子型杀菌剂。
卤代二苯基醚2’,4,4’-三氯-2-羟基-二苯基醚〔二氯苯氧氯酚〕(Triclosan)2,2’-二羟基-5,5’-二溴-二苯基醚
酚类化合物(包括苯酚和它的同系物,单烷基、多烷基和芳香族卤代酚,间苯二酚和它的衍生物,双酚类化合物和卤代N-水杨酰苯胺)。
苯酚和它的同系物
苯酚
2甲基 -苯酚
3甲基 -苯酚
4甲基 -苯酚
4乙基 -苯酚
2,4-二甲基 -苯酚
2,5-二甲基 -苯酚
3,4-二甲基 -苯酚
2,6-二甲基 -苯酚
4-正丙基 -苯酚
4-正丁基 -苯酚
4-正戊基 -苯酚
4-叔戊基 -苯酚
4-正己基 -苯酚
4-正庚基 -苯酚单烷基,多烷基和芳香族卤代酚对氯苯酚甲基 -对氯苯酚乙基-对氯苯酚正丙基 -对氯苯酚正丁基 -对氯苯酚正戊基 -对氯苯酚仲戊基 -对氯苯酚正己基 -对氯苯酚环己基 -对氯苯酚正庚基 -对氯苯酚正辛基 -对氯苯酚邻氯苯酚甲基 -邻氯苯酚乙基-邻氯苯酚正丙基 -邻氯苯酚正丁基 -邻氯苯酚正戊基 -邻氯苯酚叔戊基 -邻氯苯酚正己基 -邻氯苯酚正庚基 -邻氯苯酚邻苄基 -对氯苯酚邻苄基间甲基 -对氯苯酚邻苄基间,间二甲基 -对氯苯酚邻苯乙基 -对氯苯酚邻苯乙基-间甲基 -对氯苯酚3-甲基 -对氯苯酚3,5-二甲基 -对氯苯酚6-乙基-3-甲基 -对氯苯酚6-正丙基-3-甲基 -对氯苯酚6-异丙基-3-甲基 -对氯苯酚2-乙基3,5-二甲基 -对氯苯酚6-仲丁基-3-甲基 -对氯苯酚2-异丙基-3,5-二甲基 -对氯苯酚6-二乙基甲基-3-甲基 -对氯苯酚6-异丙基-2-乙基-3-甲基 -对氯苯酚2-仲戊基-3,5-二甲基 -对氯苯酚2-二乙基甲基-3,5-二甲基 -对氯苯酚6-仲辛基-3-甲基 -对氯苯酚对溴苯酚甲基 -对溴苯酚乙基 -对溴苯酚正丙基 -对溴苯酚正丁基 -对溴苯酚正戊基 -对溴苯酚仲戊基 -对溴苯酚正己基 -对溴苯酚环己基 -对溴苯酚邻溴苯酚 叔戊基 -邻溴苯酚正己基 -邻溴苯酚2-丙基-间,间-二甲基 -邻溴苯酚2-苯基苯酚4-氯-2-甲基苯酚4-氯-3-甲基苯酚4-氯-3,5-二甲基苯酚2,4-二氯-3,5-二甲基苯酚3,4,5,6-四溴-2-甲基苯酚5-甲基-2-戊基苯酚4-异丙基-3-甲基苯酚5-氯-2-羟基二苯基甲烷间苯二酚和它的衍生物
间苯二酚
甲基 -间苯二酚
乙基 -间苯二酚
正丙基 -间苯二酚
正丁基 -间苯二酚
正戊基 -间苯二酚
正己基 -间苯二酚
正庚基 -间苯二酚
正辛基 -间苯二酚
正壬基 -间苯二酚
苯基 -间苯二酚
苄基 -间苯二酚
苯乙基 -间苯二酚
苯丙基 -间苯二酚
对氯苄基 -间苯二酚
5-氯 -2,4-二羟基二苯基甲烷
4’-氯 -2,4-二羟基二苯基甲烷
5-溴 -2,4-二羟基二苯基甲烷
4’-溴 -2,4-二羟基二苯基甲烷双酚类化合物
2,2’-亚甲基二(4-氯苯酚)
2,2’-亚甲基二(3,4,6-三氯苯酚)
2,2’-亚甲基二(4-氯-6-溴苯酚)
二(2-羟基-3,5-二氯苯基)硫醚
二(2-羟基-5-氯苯基)硫醚
卤代N-水杨酰苯胺
4’,5-二溴N-水杨酰苯胺
3,4’,5-三氯N-水杨酰苯胺
3,4’,5’-三溴N-水杨酰苯胺
2,3,3’,5-四氯N-水杨酰苯胺
3,3’,5-三氯N-水杨酰苯胺
3,5-二溴-3’-三氟甲基N-水杨酰苯胺
5-正辛酰基-3’-三氟甲基N-水杨酰苯胺
3,5-二溴-4’-三氟甲基N-水杨酰苯胺
3,5-二溴-3’-三氟甲基N-水杨酰苯胺
(氟苯)
苯甲酸酯
对羟基苯甲酸
甲基 -对羟基苯甲酸
乙基 -对羟基苯甲酸
丙基 -对羟基苯甲酸
丁基 -对羟基苯甲酸
卤代N-碳酰苯胺
3,4,4’-三氟N-碳酰苯胺
3-三氟甲基-4,4’-二氯N-碳酰苯胺
3,3’,4-三氯N-碳酰苯胺
杀菌剂在制备的口用组合物中的含量为有效抗牙斑量,典型的是0.01—5%(重量百分比),约以0.03—1%为佳。该杀菌剂基本不溶于水,即,25℃时它在水中的溶解度小于1%(重量百分比)甚至可能小于0.1%。如果其中含有可电离基团,溶解度的测定在一个不发生电离的pH下进行。表面活性剂
本发明组合物可使用许多不同的表面活性剂。在一个较宽的pH范围内能比较稳定而且有效的表面活性剂均适用。其中包括非皂阴离子型,非离子型,阳离子型,两性离子型和两性有机合成表面活性剂。其中的许多种被Gieseke等公开于在此全文引为参考的1988年9月27晶的美国专利4,051,234。
优先的表面活性剂包括烷基硫酸盐。表面活性剂的含量一般约为0.2%—7%,约以0.6—4.0%为佳。水
本发明组合物中还含有水。用于制备组合物商品的水最好应该是去离子水而且不含有机杂质。此处牙膏型组合物的含水量(重量百分比)一般约为10%—50%,以20%—40%为佳,而漱口液中的含水量一般为40%—95%,以50%—80%为佳。这些水包括加入的游离水以及随山梨醇等物质带入的水。溶剂
本发明组合物中含有一种溶剂。该溶剂用于溶解杀菌剂而且可以是许多种试剂。
优先试剂包括下文将要说明的香味油或是这样一些试剂,如,分子量最好为200—600的聚乙二醇,丙二醇,二丙二醇,甲基溶纤剂,乙基溶纤剂,橄榄油,蓖麻油,乙酸戊酯,乙酸乙酯,三硬脂酸甘油酯,苯甲酸苄酯及它们的混合物。该溶剂的含量一般为1—10%,约以2—6%为佳。碳酸氢盐
本发明组合物中的另一必需组分是一种碳酸氢盐,最好是一种碱金属盐。优选的碳酸氢盐是碳酸氢钠,这是一种主要商品原料。碳酸氢盐的含量一般为1%—50%,以1.5%—25%为佳,5%—25%最好。任选组分
本发明组合物除上述组分外还可能含有许多其它物质,这些物质在某种程度上取决于组合物的类型(漱口液,牙膏,表面凝胶,预防牙膏等)。优选牙膏和漱口液,以牙膏为最优。
牙膏中含有作为主要组分之一的一种磨料。被考虚用于本发明的抛光磨料可以是不会过度磨损牙质的任何物质。其中包括:例如,二氧化硅凝胶和沉淀,碳酸钙,二水合正磷酸二钙,焦磷酸钙,磷酸三钙,聚偏磷酸钙,不溶性聚偏磷酸钠,水合氧化铝,和诸如尿素和甲醛的缩合颗粒产物的树脂类磨料物质,以及在此参考的1962年12月25日Cooley等的美国专利3,070,510中公开的其他物质。也可以使用它们的混合物。
各种二氧化硅牙齿磨料具有优良的口腔清洁作用和抛光牙表面而不过度磨损牙珐琅质或牙质的优点。二氧化硅磨料还具有优良的与可溶性氟离子和其它离子源的相容性。出于上述原因,优选使用之。
此处所用的二氧化硅抛光磨料和其它磨料的平均颗粒大小一般在0.1—30微米之间,以5—15微米为佳。该二氧化硅磨料可以是沉淀二氧化硅或是诸如在此引为参考的1970年3月2日授权的Pader等的美国专利3,538,230和1975年7月21日DiGiulio等的美国专利3,862,307中所述的二氧化硅干凝胶。优选的是W.R.Grace和Company,Davison Chemical Division出品的商品名为“Syloid”的二氧化硅干凝胶。优选的沉淀二氧化硅磨料包括J.M.Huber Cor-poration的“Zeodent”,特别是牌号为“Zeodent 119”的二氧化硅。有关这些二氧化硅磨料的描述可见于1982年7月29日的美国专利4,340,583,在此引为参考。
在此描述的洁牙组合物中的磨料含量约为6%—70%,如果是牙膏,该含量以15%—30%为佳。
正如过去所提到过的,还可以在本发明的牙膏和其他类型组合物中加入香味剂。适用的香味剂包括冬青油,薄荷油,黄樟油,和子丁香油。还可加入甜味剂,其中包括天冬酰苯丙氨酸甲酯(Aspartame),acesulfame,糖精,葡萄糖,果糖和环己基氨基磺酸钠。组合物中香味剂和甜味剂的含量一般为0.005%—2%(重量),而且可以用作前述杀菌剂的溶剂。
制备牙膏时,为了获得合适的稠度,必需加入一些增稠剂。优先的增稠剂是羧基乙烯基聚合物,角叉菜聚糖(carrageenan),羟乙基纤维素和诸如羧基甲基纤维素钠和羧基甲基羟乙基纤维素钠之类的纤维素醚的水溶性盐。也可以使用诸如卡拉胶,阿拉伯树胶和黄蓍胶之类的天然树胶和以黄原胶为例的聚糖树胶。胶态的硅酸铝镁或是二氧化硅细粉可被用作部分增稠剂以改进其组织结构。组合使用的增稠剂可以占组合物总重的0.5%—5.0%。
牙膏中还宜含有一种可防止硬化的保湿剂。适用的保湿剂包括甘油,山梨醇,和其他可食的多羟基醇类,其含量约为10%—70%。
本发明的另一种优选实施方法是制成漱口剂型组合物。漱口剂中一般含有约20∶1至2∶1的水/乙醇溶液及其它优选组分,如上述的香味剂,甜味剂,保湿剂和起泡剂。甘油和山梨醇之类的保湿剂可使口感润湿。一般,本发明中的漱口剂含有(重量百分比):5%—60%(以10%—25%为佳)的乙醇,0%—20%(以5%—20%为佳)的保湿剂,0%—2%(以0.01—0.15%为佳)的乳化剂,0%—0.5%(以0.005%—0.06%为佳)的糖精之类的甜味剂,0%—0.3%(以0.03%—0.3%为佳)的香味剂,和余量的水。
该组合物的pH和/或它在口中的pH可以是对口腔中的软硬组织安全的任意值。这样的pH值一般约在5—10,约以8.5—9.5为佳。
本发明组合物的另一任选组分是一种阴离子型聚羧化物。在此任选但却最好选用的阴离子聚合型聚羧化物是为人熟知的,其应用形式可以是它们的游离酸或是部分或最好是全部被中和的水溶性碱金属盐(例如,优选钠盐)或铵盐。优选的是马来酐或酸与另一可聚合烯属不饱和单体,最好是甲基·乙烯基醚(甲氧基乙烯)的1∶4至4∶1共聚物,其分子量(M.W.)约为30,000—1,000,000。这类共聚物可得的有例如Gantrez AN 139(M.W.500,000),A.N.119(M.W.250,000)而且优选GAF Corporation的S-97药用级(M.W.70,000)。
其它可用的聚合型聚羧化物包括马来酸酐和丙烯酸乙酯,丙烯酸羟乙酯,N-乙烯基-2-吡咯烷酮,或乙烯的1∶1共聚物,(后者中可购得的有Monsanto EMA No.1103,M.W.10,000和EMA Grade61),和丙烯酸与甲基丙烯酸甲酯或羟乙酯,丙烯酸甲酯或乙酯,异丁基乙烯基醚或N-乙烯基-2-吡咯烷酮的1∶1共聚物。
在此引为参考的美国专利4,138,477和4,183,914中公开的可用的聚合型聚羧化物还包括马来酸酐与苯乙烯,异丁烯或乙基·乙烯基醚的共聚物,聚丙烯酸,聚衣康酸和聚马来酸,和以UniroyalND—2为例的分子量低至1,000的磺基丙烯酸寡聚物。
通常适用的是含有一个活泼的碳碳双键和至少一个羧基的聚合烯属不饱和烯酸,即该酸具有一个在聚合反应中易打开的双键,因为它位于单体分子中相对于羧基的α-β位或是构成一个位于终端的亚甲基。这些酸有丙烯酸,甲基丙烯酸,乙基丙烯酸,α-氯丙烯酸,巴豆酸,β-丙烯酰氧基丙酸(β-acryloxy丙酸),山梨酸,α-氯山梨酸,肉桂酸,β-苯乙烯基丙烯酸,粘康酸,衣康酸,柠康酸,中康酸,戊烯二酸,乌头酸,α-苯基丙烯酸,2-苄基丙烯酸,2-环己基丙烯酸,当归酸,繖形酸,富马酸,马来酸和它们的酸酐。其它可与这些羧酸单体聚合的不同的烯属单体包括乙酸乙烯酯,氯乙烯,马来酸二甲酯等。共聚物中含有足量的提供水溶性的羧酸盐基团。
在此还可以使用羧基乙烯基聚合物,上文被归为合适的粘合剂,在以下专利中被公开为牙膏组分:1976年9月14日授权于Choun等的美国专利3,980,767,1976年1月27日授权Roberts等的美国专利3,935,306,1975年11月11日授权Peria等的美国专利3,919,409,1975年10月7日授权Harrison等的美国专利3,911,904,和1973年1月16日授权Colodney等的美国专利3,711,604。可购得的有例如B.F.Goodrich的Carbopol 934,940,941和956(商品名),这些产品主要含有胶状水溶性丙烯酸交联聚合物,其中含有0.75%—2.0%的聚烯丙基蔗糖或聚烯丙基季戊四醇作为交联剂。
这一类合成阴离子聚羧化物组分主要是一种烃,它具有任选的卤素和含氧取代基和键(例如存在于酯基,醚基和OH基团的),在该组合物中的重量百分比含量一般约为0.05—3%,以0.05—2%为佳,0.1—2%更好。
另一种可选组分是某种氟离子源。根据本发明适用的氟离子源,或是供氟化合物是本行中熟知的抗龋齿剂和焦磷酸酶抑制剂,用于本发明时,它们仍具有上述作用。这些化合物可以是微溶于水或是全溶于水的。其特点在于,它们可以在水中释放出氟离子而且不会与口用组合物中的其它组分发生不利的反应。这类物质中有以可溶性碱金属盐,碱土金属盐为例的无机含氟盐,例如氟化钠,氟化钡,氟硅酸钠,氟硅酸铵,氟锆酸钠,单氟磷酸钠,单氟和双氟磷酸铝,和氟化的焦磷酸钙钠。优选碱金属和锡的氟化物,例如氟化钠,氟化亚锡,单氟磷酸钠(MFP)及它们的混合物。
供氟化合物的含量在某种程度上取决于化合物的类型,溶解度,和口用制剂的类型,但这必须是个无毒量,一般约占制剂的0.005—3.0%。在洁齿制剂中,例如牙凝胶,牙膏(包括乳液),认为此类化合物令人满意的含量应能释放多至约5,000ppm的F离子(按制剂的总重计)。可以使用任何合适的最小剂量,但用量以足够释放出约300—2,000ppm的氟离子为宜,800—1,500ppm更好。通常,若以碱金属氟化物和氟化亚锡为例,该组分重量百分比含量约多至2%,以O.05%—1%为宜。以单氟磷酸钠为例,以含量约为0.1—3%,以0.76%为佳。
本组合物中还有一可选组分,即非聚合抗牙石剂。这些试剂包括以在此参考的1985年5月7日的美国专利4,515,772中描述的焦磷酸盐为例的任何可有效防治牙石的试剂。优选的是焦磷酸的一,二,三,四碱金属盐和铵盐。其用量应能有效消除牙石。该用量至少约有1%的P2O7,至少1.3%更好,不低于1.5%最好。
其它抗牙石剂有以在此参考的1977年5月10日Vinson的美国专利4,022,880中所述的锌为例的金属离子。还有如在此参考的1987年4月28日Benedict的美国专利4,661,341和1969年2月25日Shedlovsky的美国专利3,429,963中所述的聚合物。所述金属离子的用量约为0.01—5%,约以0.1%—2%为佳,而所述聚合物的用量约为0.1%—10%,以0.5%—5%为佳。
其它抗牙石剂还有在此全面参考的美国专利3,988,443和美国专利3,488,419中所述的二膦酸盐。生产方法
可利用实施例中所述方法制备本发明组合物。组合物的使用
在本发明方法方面的内容中涉及将安全有效量的抗菌剂用于口腔。通常,抗菌剂的有效试量至少约为0.001g。
以下给出的代表本发明的两个实施例。它们描述并表明的本发明范围内的优选实施方法。
给出实施例仅以说明为目的而应被认为是对本发明的限制。在不背离本发明的精神与范围的条件下还可以有许多可变方案。实施例1
以下给出的是根据本发明的防治牙石组合物。
组分 重量%
二氯苯氧氯酚(Triclosan) 0.450
氟化钠(美国药典) 0.243
焦磷酸四钠 5.045
纯水(美国药典) 19.621
甘油(美国药典) 15.000
聚乙二醇300(国家药典) 3.000
羧甲基纤维素 0.700
碳酸钠 3.000
碳酸氢钠 20.000
沉淀二氧化硅 18.000
二氧化钛(美国药典) 0.350
烷基硫酸钠(28%的溶液) 4.000
糖精钠(美国药典) 0.530
香味剂 1.000
山梨醇溶液(美国药典) 9.061
制备上述组合物时,最好先制备一些预混合物,然后按特定顺序将它们混合。
1.预混合物1含:水,山梨醇,氟化钠,糖精钠,碳酸钠,甘油或其它可选水溶性物质。
2.预混合物2含:香味剂,二氯苯氧氯酚,聚乙二醇和烷基硫酸钠溶液。
3.预混合物3含:碳酸氢钠,二氧化钛,二氧化硅和羧甲基纤维素。
4.预混合物4含:焦磷酸四钠和甘油。
所有预聚合物都经充分混合,预混合物2需混合足够时间以溶解全部二氯苯氧氯酚。预混合物按列出的顺序相混合(即,预混合物2与预混合物1混合,然后向1和2的混合物中加入预混合物3,以此类推)。将预混合物2与1混合时,需充分搅拌并混合足够长的时间从而确保二氯苯氧氯酚以水溶性酚盐的形式溶解,同时形成二氯苯氧氯酚、香味剂和表面活性剂微乳剂。实施例II
以下给出的是代表本发明的另一种组合物。
组分 重量%
二氯苯氧氯酚(Triclosan) 0.450
氟化钠(美国药典) 0.243
纯水(美国药典) 24.666
甘油(美国药典) 15.000
聚乙二醇300(国家药典) 3.000
羧甲基纤维素 0.700
碳酸钠 3.000
碳酸氢钠 20.000
沉淀二氧化硅 18.000
二氧化钛(美国药典) 0.350
烷基硫酸钠(28%的溶液) 4.000
糖精钠(美国药典) 0.530
香味剂 1.000
山梨醇溶液(美国药典) 9.061
实施例III以下给出的另一种组合物。
组分 重量%
二氯苯氧氯酚 0.280
氟化钠 0.243
二氧化硅 30.000
反渗析水(RO Water) 23.954
甘油 13.000
山梨醇 6.650
烷基硫酸钠溶液 6.000
焦磷酸四钠 5.045
碳酸氢钠 5.000
聚乙二醇6 4.000
碳酸钠 2.850
香味剂BSTC 1.100
羧甲基纤维素12M8P 1.000
糖精 0.528
二氧化钛 0.350
pH 9.0
Claims (17)
1.一种含水口用组合物,其特征在于,它含有:非阳离子非水溶性杀菌剂,所述杀菌剂的溶剂,表面活性剂,碳酸氢盐和水,而且所述组合物的净pH约为8.5—9.5,所述组合物基本不含钾离子。
2.根据权利要求1所述的组合物,其特征在于,其中所述溶剂是一种香味油,而碳酸氢盐是碳酸氢钠。
3.根据权利要求1所述的组合物,其特征在于,其中所述溶剂是乙二醇。
4.根据权利要求1所述的组合物,其特征在于,其中所述溶剂是香味油与乙二醇的混合物。
5.根据权利要求·2所述的组合物,其特征在于,其中所述组合物是牙膏或是漱口剂。
6.根据权利要求5所述的组合物,其特征在于,其中的组合物是牙膏而碳酸氢钠的含量约为1.5%—50%。
7.根据权利要求6所述的组合物,其特征在于,其中所述牙膏含有磨料。
8.根据权利要求7所述的组合物,其特征在于,其中所述牙膏还含有杀菌剂二氯苯氧氯酚,而且表面活性剂含量与杀菌剂加香味剂的含量之比大于等于可形成杀菌剂微乳剂的临界点。
9.根据权利要求8所述的组合物,其特征在于,其中所述牙膏含有可溶性氟离子源。
10.根据权利要求9所述的组合物,其特征在于,其中所述牙膏含有抗牙石剂。
11.根据权利要求10所述的组合物,其特征在于,其中所述抗牙石剂是可溶性焦磷酸盐或是可溶性二膦酸盐。
12.根据权利要求11所述的组合物,其特征在于,其中的抗牙石剂是焦磷酸钠或2,2-二膦酸氮杂环烷酯(azacycloalkane—2,2—diphosphonate)。
13.一种治疗口腔疾病的方法,其特征在于将有效量的权利要求1所述组合物用于口腔。
14.根据权利要求13所述的治疗方法,其特征在于将有效量的权利要求4所述组合物用于口腔。
15.根据权利要求13所述的治疗方法,其特征在于将有效量的权利要求6所述组合物用于口腔。
16.根据权利要求13所述的治疗方法,其特征在于将有效量的权利要求9所述组合物用于口腔。
17.根据权利要求13所述的治疗方法,其特征在于将有效量的权利要求11所述组合物用于口腔。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/045,743 US5290542A (en) | 1993-04-08 | 1993-04-08 | Oral compositions for treating plaque and gingivitis |
US08/201,599 US5474761A (en) | 1993-04-08 | 1994-02-25 | Oral compositions for treating plaque and gingivitis |
US08/201,599 | 1994-02-25 | ||
US08/045,743 | 1994-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1126432A true CN1126432A (zh) | 1996-07-10 |
Family
ID=26723153
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN94192315.0A Pending CN1126432A (zh) | 1993-04-08 | 1994-03-25 | 用于治疗牙斑和牙龈炎的含有非阳离子型杀菌剂和碳酸氢盐的口用组合物 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5474761A (zh) |
EP (1) | EP0693919B1 (zh) |
JP (1) | JPH08508751A (zh) |
CN (1) | CN1126432A (zh) |
AT (1) | ATE174786T1 (zh) |
AU (1) | AU690546B2 (zh) |
BR (1) | BR9406041A (zh) |
CA (1) | CA2159984C (zh) |
CZ (1) | CZ260695A3 (zh) |
DE (1) | DE69415515T2 (zh) |
DK (1) | DK0693919T3 (zh) |
ES (1) | ES2125447T3 (zh) |
HU (1) | HUT73785A (zh) |
WO (1) | WO1994023691A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108289800A (zh) * | 2015-12-14 | 2018-07-17 | 花王株式会社 | 液体口腔用组合物 |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5326554A (en) * | 1993-04-23 | 1994-07-05 | The Procter & Gamble Company | Oral compositions for treating plaque and gingivitis |
GB9500746D0 (en) * | 1995-01-14 | 1995-03-08 | Procter & Gamble | Oral compositions |
ES2205235T3 (es) * | 1996-06-07 | 2004-05-01 | Hercules Incorporated | Composiciones de pasta de dientes que contienen suspensiones fluidificadas de polimero de carboximetilcelulosa. |
US5855871A (en) * | 1997-08-12 | 1999-01-05 | Colgate-Palmolive Company | Effervescent two component bicarbonate and acid containing dentifrice |
US6280707B1 (en) | 1998-12-15 | 2001-08-28 | Dentsply International Inc. | Oral prophalaxis paste |
US6592912B1 (en) * | 1997-12-30 | 2003-07-15 | Wm. Wrigley Jr. Company | Method of controlling release of antimicrobial agents from chewing gum and gum produced thereby |
DE10017997A1 (de) | 2000-04-11 | 2001-10-18 | Henkel Kgaa | Belaghemmendes flüssiges Zahnreinigungsgel |
US20090324515A1 (en) * | 2006-12-01 | 2009-12-31 | Barra Jerome | Antimicrobial flavouring composition |
BRPI0914031B1 (pt) * | 2008-10-20 | 2023-12-12 | Unilever Ip Holdings B.V. | Uso de uma composição para higiene das mãos |
MX2012003563A (es) | 2009-09-24 | 2012-04-30 | Unilever Nv | Agente desinfectante que comprende eugenol, terpineol y timol. |
US9084902B2 (en) | 2010-06-30 | 2015-07-21 | Mcneil-Ppc, Inc. | Non-alchohol bioactive essential oil mouth rinses |
BR112013014028A2 (pt) * | 2010-12-07 | 2016-07-12 | Unilever Nv | composição de enxague bucal, uso e método |
BR112013013085B1 (pt) | 2010-12-07 | 2018-02-14 | Unilever N.V. | Composição de cuidados orais, enxaguante bucal, creme dental, dentífrico, método para desinfetar a cavidade oral e uso de uma composição |
US9693941B2 (en) | 2011-11-03 | 2017-07-04 | Conopco, Inc. | Liquid personal wash composition |
EP3576755A4 (en) | 2017-02-02 | 2020-12-02 | McMaster University | BICARBONATE AS A POTENTIATOR FOR ANTIMICROBIAL INGREDIENTS |
WO2020024060A1 (en) | 2018-08-01 | 2020-02-06 | Mcmaster University | Methods for inhibiting microbe growth |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4022880A (en) * | 1973-09-26 | 1977-05-10 | Lever Brothers Company | Anticalculus composition |
US4293544A (en) * | 1979-03-07 | 1981-10-06 | Finetex Incorporated | Fluid and semi-fluid compositions including benzoate esters |
CA1177756A (en) * | 1980-10-23 | 1984-11-13 | Donald F. Loncrini | Compositions of p-hydroxybenzoic acid esters and methods of preparation and use |
IT1150603B (it) * | 1982-01-26 | 1986-12-17 | Ugo Baldacci | Composizione per la pulizia e l'igiene dentaria |
US4512987A (en) * | 1982-07-15 | 1985-04-23 | Ciba-Geigy Corporation | New pharmaceutical preparations |
US4568480A (en) * | 1983-11-17 | 1986-02-04 | Basf Wyandotte Corporation | Microemulsions |
GB8401965D0 (en) * | 1984-01-25 | 1984-02-29 | Beecham Group Plc | Composition |
US4940701A (en) * | 1984-01-25 | 1990-07-10 | Beecham Group P.L.C. | Topical drug release system |
GB8411731D0 (en) * | 1984-05-09 | 1984-06-13 | Unilever Plc | Oral compositions |
GB8411841D0 (en) * | 1984-05-09 | 1984-06-13 | Unilever Plc | Oral compositions |
GB8526093D0 (en) * | 1985-10-22 | 1985-11-27 | Beecham Group Plc | Composition |
GB8615534D0 (en) * | 1986-06-25 | 1986-07-30 | Beecham Group Plc | Composition |
US5178851A (en) * | 1987-01-30 | 1993-01-12 | Colgate-Palmolive Company | Antiplaque antibacterial oral composition |
US4894220A (en) * | 1987-01-30 | 1990-01-16 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
US5032386A (en) * | 1988-12-29 | 1991-07-16 | Colgate-Palmolive Company | Antiplaque antibacterial oral composition |
IN168400B (zh) * | 1987-01-30 | 1991-03-23 | Colgate Palmolive Co | |
US5156835A (en) * | 1987-01-30 | 1992-10-20 | Colgate-Palmolive Company | Antibacterial antiplaque oral composition |
US5180578A (en) * | 1987-01-30 | 1993-01-19 | Colgate-Palmolive Company | Antibacterial antiplaque anticalculus oral composition |
US5256401A (en) * | 1987-01-30 | 1993-10-26 | Colgate-Palmolive Company | Antibacterial antiplaque mouthwash composition |
IE60024B1 (en) * | 1987-02-03 | 1994-05-18 | Stiefel Laboratories Ltd | Microemulsions |
JPH0629174B2 (ja) * | 1987-02-12 | 1994-04-20 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 疼痛敏感な歯を除痛するための歯みがき組成物 |
US4842766A (en) * | 1987-02-17 | 1989-06-27 | Dow Corning Corporation | Silane microemulsions |
US4835002A (en) * | 1987-07-10 | 1989-05-30 | Wolf Peter A | Microemulsions of oil in water and alcohol |
US5160669A (en) * | 1988-03-03 | 1992-11-03 | Micro Vesicular Systems, Inc. | Method of making oil filled paucilamellar lipid vesicles |
US5167951A (en) * | 1988-12-29 | 1992-12-01 | Colgate-Palmolive Company | Article comprising a dispensing container that includes solid polymeric material in contact with an antiplaque oral composition with which it is compatible |
US4971788A (en) * | 1989-01-27 | 1990-11-20 | Medicontrol Corporation | Oral cavity and dental microemulsion products |
US5130122A (en) * | 1989-01-27 | 1992-07-14 | Medicontrol Corporation | Oral cavity and dental microemulsion products |
US5284648A (en) * | 1989-03-17 | 1994-02-08 | White Robert D | Alcohol-free, oral rinse and pre-rinse emulsions method of prepration and method of use |
GB9007074D0 (en) * | 1990-03-29 | 1990-05-30 | Beecham Inc | Novel compositions |
US4992259A (en) * | 1990-01-03 | 1991-02-12 | Johnson & Johnson Consumer Products, Inc. | Stable oral composition of zinc |
US5045337A (en) * | 1990-04-19 | 1991-09-03 | The Procter & Gamble Company | Food microemulsion |
US5162378A (en) * | 1990-04-20 | 1992-11-10 | Revlon Consumer Products Corporation | Silicone containing water-in-oil microemulsions having increased salt content |
EP0466236B1 (en) * | 1990-07-11 | 1994-08-17 | Quest International B.V. | Perfumed structured emulsions in personal products |
HUT63323A (en) * | 1990-07-13 | 1993-08-30 | Procter & Gamble | Composition against dental deposits, comprissing azacycloalkane diphosphonates |
US5180577A (en) * | 1990-10-09 | 1993-01-19 | Colgate-Palmolive | Stabilized bis biguanide/anionic active ingredient compositions |
AU9179791A (en) * | 1990-12-19 | 1992-07-22 | Procter & Gamble Company, The | Oral compositions effective against plaque and gingivitis |
US5188822A (en) * | 1991-08-07 | 1993-02-23 | Chesebrough-Pond's Usa Co., Division Of Conopco Inc. | Oral compositions containing an aminosilicone and a lipophilic compound |
US5215740A (en) * | 1991-10-25 | 1993-06-01 | Church & Dwight Co., Inc. | Buffering system for anticalculus dentifrices |
US5234495A (en) * | 1991-12-02 | 1993-08-10 | Union Carbide Chemicals & Plastics Technology Corporation | Process for the emulsification of polydimethyl siloxane oils, organomodified siloxane oils and organic oil using non-ionic surfactants |
US5290541A (en) * | 1992-06-18 | 1994-03-01 | The Procter & Gamble Company | Methods for making oral compositions |
US5236699A (en) * | 1992-06-22 | 1993-08-17 | Libin Barry M | Antiplaque mouth rinse |
US5290542A (en) * | 1993-04-08 | 1994-03-01 | The Procter & Gamble Company | Oral compositions for treating plaque and gingivitis |
US5283056A (en) * | 1993-07-01 | 1994-02-01 | International Flavors & Fragrances Inc. | Transparent oil-in-water microemulsion flavor or fragrance concentrate, process for preparing same, mouthwash or perfume composition containing said transparent microemulsion concentrate, and process for preparing same |
-
1994
- 1994-02-25 US US08/201,599 patent/US5474761A/en not_active Expired - Lifetime
- 1994-03-25 BR BR9406041A patent/BR9406041A/pt not_active Application Discontinuation
- 1994-03-25 JP JP6523206A patent/JPH08508751A/ja active Pending
- 1994-03-25 HU HU9502932A patent/HUT73785A/hu unknown
- 1994-03-25 ES ES94912315T patent/ES2125447T3/es not_active Expired - Lifetime
- 1994-03-25 CZ CZ952606A patent/CZ260695A3/cs unknown
- 1994-03-25 EP EP94912315A patent/EP0693919B1/en not_active Expired - Lifetime
- 1994-03-25 WO PCT/US1994/003281 patent/WO1994023691A2/en not_active Application Discontinuation
- 1994-03-25 AU AU64925/94A patent/AU690546B2/en not_active Ceased
- 1994-03-25 DK DK94912315T patent/DK0693919T3/da active
- 1994-03-25 CN CN94192315.0A patent/CN1126432A/zh active Pending
- 1994-03-25 DE DE69415515T patent/DE69415515T2/de not_active Expired - Fee Related
- 1994-03-25 CA CA002159984A patent/CA2159984C/en not_active Expired - Fee Related
- 1994-03-25 AT AT94912315T patent/ATE174786T1/de not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108289800A (zh) * | 2015-12-14 | 2018-07-17 | 花王株式会社 | 液体口腔用组合物 |
Also Published As
Publication number | Publication date |
---|---|
EP0693919A1 (en) | 1996-01-31 |
AU6492594A (en) | 1994-11-08 |
DE69415515D1 (de) | 1999-02-04 |
EP0693919B1 (en) | 1998-12-23 |
HUT73785A (en) | 1996-09-30 |
ES2125447T3 (es) | 1999-03-01 |
DE69415515T2 (de) | 1999-07-29 |
BR9406041A (pt) | 1996-02-06 |
AU690546B2 (en) | 1998-04-30 |
HU9502932D0 (en) | 1995-11-28 |
ATE174786T1 (de) | 1999-01-15 |
CZ260695A3 (en) | 1996-06-12 |
CA2159984C (en) | 1999-06-15 |
CA2159984A1 (en) | 1994-10-27 |
US5474761A (en) | 1995-12-12 |
WO1994023691A3 (en) | 1995-01-12 |
WO1994023691A2 (en) | 1994-10-27 |
DK0693919T3 (da) | 1999-08-23 |
JPH08508751A (ja) | 1996-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1126432A (zh) | 用于治疗牙斑和牙龈炎的含有非阳离子型杀菌剂和碳酸氢盐的口用组合物 | |
CN1303969C (zh) | 提供增强的整体清洁效果的口腔组合物 | |
CN1062653A (zh) | 抗齿垢口腔用配方 | |
CN1154471C (zh) | 减少洁牙剂组合物中亚锡涩味的方法 | |
CN1287803C (zh) | 促进全身健康的局部口腔组合物及其应用 | |
CN1048867C (zh) | 洁牙剂 | |
CN1200685C (zh) | 亚锡口腔组合物 | |
CN1071110C (zh) | 一种用于刷牙的制剂 | |
CN100350894C (zh) | 包含二羧基官能化聚有机硅氧烷的口腔护理组合物 | |
JP4008968B2 (ja) | デンタルインプラント領域への抗菌性口腔用組成物の適用方法 | |
CN1744873A (zh) | 稳定的包含亚氯酸盐的口腔护理组合物 | |
CN1083700A (zh) | 制造非牛顿型膏、霜状制品的连续方法 | |
CN1446075A (zh) | 含亚氯酸盐的口腔护理组合物和口腔护理方法 | |
CN1925828A (zh) | 薄膜组合物 | |
CN1610535A (zh) | 包含酪蛋白磷酸肽复合物和氟化物的稳定的口腔用组合物 | |
CN1440268A (zh) | 促进全身健康 | |
TW201630587A (zh) | 含四鹼基鋅-胺基酸-鹵化物複合物之口腔保健產品 | |
IE53979B1 (en) | Anticaries composition | |
TW201010735A (en) | Oral compositions and uses thereof | |
CN1220596A (zh) | 含有十六烷基氯化吡啶鎓和一种两性表面活性剂的漱口药组合物 | |
TW201235053A (en) | Oral care product and methods of use and manufacture thereof | |
CN1040142A (zh) | 口用组合物 | |
CN1158081A (zh) | 口腔用组合物 | |
JP2008074774A (ja) | 口腔用組成物 | |
US20080292566A1 (en) | Oral composition containing morin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1022234 Country of ref document: HK |